Researchers uncovered serum proteome biomarkers to predict eGFR decline in patients with ADPKD. Proposed causes of eGFR difference did not account for its association with adverse outcomes in CKD. Sex inequities in kidney transplant wait-listing have improved but remain significant, a study found. Crescents and cellular segmental sclerosis predicted greater benefit from glucocorticoids in IgA nephropathy. Researchers set out to determine the optimal systolic BP for achieving kidney protection in middle-aged and older patients. The time of day when antihypertensives are given has little effect on benefits and risks among older, frail patients. This Freely Filtered episode discusses the use of intranasal desmopressin to help prevent bleeding from kidney biopsy. The panelists share their excitement about the future of glomerulonephritis therapies. The panel discusses the logistics of implementing the new treatments for C3G and IC-MPGN. The panel discusses the role of kidney biopsies in the clinical trials of iptacopan and pegcetacoplan for C3G. Our panel discusses two recently approved treatments, iptacopan for C3G and pegcetacoplan for C3G and IC-MPGN. Our panel discusses the history of C3G/IC-MPGN, the heterogeneity of glomerulonephritis, and new disease definitions. A study examined patients at two Danish hospitals receiving a shared decision-making and dialysis choice intervention. Real-world data provided strong evidence supporting GLP-1 RA use in patients with diabetes receiving dialysis. A study shed light on the association between childhood cancer treatment and CKD or hypertension after treatment. Researchers identified a combination biomarker panel to predict chronic kidney disease progression among children. A study assessed whether early dd-cfDNA levels and their relative changes could predict long-term graft survival. A population health management intervention for CKD lowered hospitalization rates but not costs. We asked five nephrologists: What technology or tool has changed your practice the most in the last 5 years? AKI is common among patients with COVID-19 infections. A study examined their long-term kidney and survival outcomes.